St. Luke's Cancer Institute — Kansas City, Missouri

St. Luke's Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Institute has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Breast Cancer, Breast Cancer, Ovarian Epithelial Cancer Recurrent.

Sponsors: University of Arkansas, Corcept Therapeutics, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Institute?

St. Luke's Cancer Institute has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Institute conducted?

St. Luke's Cancer Institute has 7 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, Breast Cancer, Ovarian Epithelial Cancer Recurrent.

Is St. Luke's Cancer Institute accredited by Crixeo Health?

Yes — St. Luke's Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Luke's Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.